Lexicon Pharmaceuticals, Inc. currently offers three late-stage assets Zynquista, Inpefa & Pilavapadin. Learn more about LXRX ...
The overlap between the work of J&J and Watts has led to a joint push to get women over 40 to focus on eye health. Together, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results